Suppr超能文献

双膦酸盐类药物所致非典型股骨干骨折:一例报告。

Bisphosphonate-induced atypical femoral shaft fracture: A case report.

作者信息

Farrukh Ameer Mustafa, Reyes Ligia Carolina Flores, Capa Gabriela Sayonara Lopez, Padilla Tania Beatriz Marin, Sunkara Vyshnavidevi, Dhakal Sandhya

机构信息

Department of Medicine, University of Galway School of Medicine, Galway, Ireland.

Department of Medicine, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.

出版信息

Radiol Case Rep. 2023 Sep 2;18(11):4048-4051. doi: 10.1016/j.radcr.2023.08.040. eCollection 2023 Nov.

Abstract

Osteoporosis is an important cause of fractures in postmenopausal women. Bisphosphonates are the first line of treatment for osteoporosis. However, long-term use of these medications has been related to atypical femoral fractures (AFF). We present a case of a 71-year-old postmenopausal woman, with a history of osteoporosis being treated with bisphosphonates for 6 years. The patient developed pain in her left hip and thigh over a period of 3-4 months. Radiographic studies showed an AFF and she was managed conservatively. Stopping bisphosphonate therapy should be an initial step in managing or limiting the progression of AFF. A drug holiday should be considered in patients who have been treated for more than 3-5 years to prevent AFFs. The risk of developing AFFs should never be ignored in this subset of patients.

摘要

骨质疏松症是绝经后女性骨折的重要原因。双膦酸盐类药物是治疗骨质疏松症的一线用药。然而,长期使用这些药物与非典型股骨骨折(AFF)有关。我们报告一例71岁绝经后女性病例,该患者有骨质疏松症病史,接受双膦酸盐类药物治疗6年。患者在3 - 4个月的时间里出现左髋部和大腿疼痛。影像学检查显示为非典型股骨骨折,对其进行了保守治疗。停用双膦酸盐类药物治疗应是处理或限制非典型股骨骨折进展的第一步。对于接受治疗超过3 - 5年的患者,应考虑药物假期以预防非典型股骨骨折。在这类患者中,发生非典型股骨骨折的风险绝不能被忽视。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33bd/10482883/5b6b8e340dc5/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验